Future Market Insights (FMI), tlalehong ea eona, e rera lefats'e ka bophara 'Maraka oa thekenoloji ea phano ea lithethefatsi e laoloang ka molomo ho ngolisa katoloso e tsotehang ho 7.2% CAGR nakong ea ponelopele ea 2017 ho isa ho 2027. Mmaraka o tla feta chelete e kenang e jang US $ 20,000 Mn ka 2017, mme ho hakanngoa hore e tla fihla hoo e ka bang $ 50,000 Mn ka 2027-qetellong.
Baetsi ba Meriana ea Oral Solid Amerika Leboea ba Kholisehile ho Finyella Bioavailability ea Bohlokoa
Tlaleho ea FMI e hakanya hore Amerika Leboea e tla lula e le 'maraka o moholo ka ho fetisisa oa theknoloji ea phepelo ea lithethefatsi e laoloang ka molomo, ka thekiso e hakantsoeng ho fihla hoo e ka bang $ 20,000 Mn ka 2027-qetellong. Kaha ke mokhoa o ratoang oa tsamaiso ea lithethefatsi ke lingaka, tlhoko ea thekenoloji ea phepelo ea lithethefatsi e laoloang ka molomo e ntse e bona keketseho e matla ea basebelisi ba Amerika Leboea. Ntle le moo, tsoelo-pele ea morao-rao ea phano ea lithethefatsi e nolofalelitse bahlahisi ba litekanyetso tse tiileng tsa molomo Amerika Leboea ho fihlela bioavailability e kholo ka ho amohela lipolanete tse ncha tsa phepelo ea lithethefatsi. Sena se lebelletsoe hape ho tsamaisa tlhokahalo ea theknoloji ea phepelo ea lithethefatsi e laoloang ka molomo sebakeng seo.
Tobetsa ho fumana Mohlala: https://www.futuremarketinsights.com/reports/sample/rep-gb-4400
Leha ho le joalo, mesebetsi e ntseng e eketseha ea lipatlisiso e amanang le limolek'hule tsa biologic, le matla a tsona a ho phekola maemo a oncology, hammoho le matsete a mmuso mesebetsing ena ea lipatlisiso li lebelletsoe ho sitisa kholo ea mmaraka Amerika Leboea. Ntle le moo, liphephetso tsa ho theha joalo ka tebello ea 'maraka bakeng sa dosing hanngoe ka letsatsi, le kholo ea matlapa a tokollo a laoloang a fanang ka khanyetso ea tlhekefetso, e hlahisitsoeng ke theknoloji ea phepelo ea lithethefatsi e laoloang ka molomo e lebelletsoe ho fokotsa kholo ea mmaraka sebakeng sena.
Mekhatlo e Mecha ea Lik'hemik'hale e Bakiloeng ke Tlhahlobo e Phahameng ea ho Hlahlobisisa ka Phatlalatso ho ea Kholisong ea Mmaraka Europe Bophirima
Yuropa Bophirima e tla ngolisa keketseho e potlakileng ka ho fetesisa 'marakeng oa lefats'e oa thekenoloji ea phepelo ea lithethefatsi e laoloang ka molomo. Khōlo ena e bakoa haholo-holo ke palo e ngata ea lik'hemik'hale tse ncha tse bakoang ke tlhahlobo e phahameng ea lisebelisoa, tse nang le ho qhibiliha ha tlaase le bioavailability. Sena se entse hore bahlahisi ba sebakeng sena ba tsetele mekhoeng ea phepelo ea lithethefatsi ka sephetho se betere sa bongaka. Ka lebaka la ho baballa litšenyehelo linaheng tsa Europe Bophirima, mahlale a ntlafatsang bioavailability e tla lula e le mokhoa o ratoang oa phano ea lithethefatsi. Lintlha tsena li lebelletsoe ho tsamaisa kholo ea mmaraka sebakeng sena.
Leha ho le joalo, lik'hamphani tse ngata tsa meriana Europe Bophirima li na le phepelo e rarahaneng, e sa sebelisoeng hantle kapa e sa sebetseng hantle. Ho rarahana ha ketane ea phepelo ho bakoa ke ho feto-fetoha ha maemo ho tlase le ho baballa litšenyehelo. Ho feta moo, ho khutsufatsa bophelo bo atlehileng ba patent hammoho le mafika a patent ke phephetso e kholo bakeng sa mefuta ea litekanyetso tse tiileng tsa molomo sebakeng sena. Lintlha tse kang tsena ho hakanngoa hore li sitisa kholo ea 'maraka Europe Bophirima.
Sistimi ea Phallo e Laoloang ke Dissolution e Tla Lula e Batloa ka Morao ho Litheknoloji tsa Phallo ea Lithethefatsi 'marakeng.
Ka theknoloji ea tokollo ea lithethefatsi, sistimi e laoloang ke dissolution e tla lula e batloa 'marakeng, e lateloe ke sistimi e laoloang ke diffusion. Bongata ba litlhare tse akaretsang tse fumanehang li fumaneha ka mokhoa oa litekanyetso tsa letlapa 'me li latela mokhoa oa ho lokolloa o laoloang ke dissolution. Lichelete tse tsoang thekisong ea sistimi e laoloang ke ho felisoa li tla feta US$ 10,000 Mn ka 2017. Tlhokahalo ea sistimi ea phepelo ea lithethefatsi e leka-lekaneng ka hydrodynamic e tla lula e le botsoa 'marakeng.
Mefuta e tiileng ea litekanyetso tsa thekenoloji ea phepelo ea lithethefatsi e laoloang ka molomo e lebelletsoe ho lula e le matla 'marakeng, e hola ho CAGR ea linomoro tse le' ngoe ho fihlela ka 2027. Lithekiso tsa karolo ea liforomo tsa litekanyetso tsa semisolid/liquid/suspensions li tla ngolisa CAGR e batlang e le tlase ho feta ea tiileng. mefuta ea litekanyetso 'marakeng ho fihlela 2027.
Libapali tsa bohlokoa tsa 'maraka tse khethiloeng tlalehong ea FMI li kenyelletsa AstraZeneca Plc., Bristol-Myers Squibb Company, Sun Pharmaceuticals Industries Ltd, Abbott Laboratories, Merck & Co. Inc.,Novartis AG, Pfizer Inc., Mylan NV, Sanofi, F. Hoffman-La -Roche Ltd., Johnson & Johnson Services, Inc., Vectura Group plc., GlaxoSmithKline plc.
Tobetsa ho fumana TOC e tebileng ea Tlaleho ena: https://www.futuremarketinsights.com/reports/oral-controlled-release-drug-delivery-technology-market/table-of-content
Mabapi le Lefapha la Bophelo bo Botle ho Future Market Insights
Future Market Insights e thusa likhoebo, mmuso, batseteli le bamameli ba amehang lekaleng la tlhokomelo ea bophelo ho tseba le ho totobatsa lintlha tsa bohlokoa tse amanang le leano la sehlahisoa, maemo a taolo, kholo ea theknoloji le litaba tse ling tsa bohlokoa ho fihlela katleho e tšoarellang. Mokhoa oa rona o ikhethileng oa ho bokella bohlale ba mebaraka o u hlomella ho rala mekhoa e khannoang ke boqapi bakeng sa khoebo ea hau. Tseba haholoanyane ka ts'ebetso ea lefapha la rona mona
Mabapi le 'Maraka oa Bokamoso oa Limaraka (FMI)
Future Market Insights (FMI) ke mofani ea ka sehloohong oa lits'ebeletso tsa bohlale ba 'maraka le lits'ebeletso tsa boeletsi, e sebeletsang bareki linaheng tse fetang 150. FMI e ikarabella ho Dubai, 'me e na le litsi tsa liphallelo UK, US le India. Litlaleho tsa morao-rao tsa lipatlisiso tsa 'maraka tsa FMI le tlhahlobo ea indasteri li thusa likhoebo ho sebetsana le mathata le ho etsa liqeto tsa bohlokoa ka boits'epo le ho hlaka har'a tlholisano e mpe. Litlaleho tsa rona tsa liphuputso tsa 'maraka tse hlophisitsoeng le tse kopantsoeng li fana ka lintlha tse ka sebetsang tse tsamaisang kholo e tsitsitseng. Sehlopha sa bahlahlobisisi ba etelletsoeng pele ke litsebi ho FMI se lula se latela mekhoa le liketsahalo tse ntseng li hlaha liindastering tse fapaneng ho netefatsa hore bareki ba rona ba itokisetsa litlhoko tse tsoelang pele tsa bareki ba bona.
Iteanye le rona:
Tsebo ea 'Maraka oa Bokamoso
Yuniti ea Che: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Bakeng sa Lipotso tsa Thekiso: [imeile e sirelelitsoe]
Bakeng sa Lipotso tsa Media: [imeile e sirelelitsoe]
Webosaete: https://www.futuremarketinsights.com
SEO U LOKELANG HO SE NKA HO SEHLOOHO ENA:
- In addition, formulation challenges such as juncture of market expectations for once-daily dosing, and growth of controlled release tablets which impart abuse resistance, incurred in oral controlled release drug delivery technology are expected to further curb growth of the market in this region.
- Solid dosage forms of oral controlled release drug delivery technology are expected to remain dominant in the market, expanding at a high single-digit CAGR through 2027.
- However, increasing research activities related to biologic molecules, and their dominance in treating oncology conditions, coupled with government investments in these research activities are expected to impede the market growth in North America.
